Intensive Care Medicine

Section I. Genomics and Proteomics

1. Rethinking Sepsis: New Insights from Gene Expression Profiling Studies
B. M. Tang, S. J. Huang, A. S. McLean

2. Mitochondrial Genetics and Sepsis
A. Pyle, P. Chinnery, S. Baudouin

3. Lung Proteomics in Intensive Care
E. Kipnis, K. Hansen

Section II. Inflammatory Response

4. The Host Response to Sepsis
T. J. Hommes, W. J. Wiersinga, T. Poll

5. Endotoxin Tolerance: Mechanisms and Clinical Applicability
A. Draisma, J. G. Hoeven, P. Pickkers

6. Oxidative Stress and Endothelial Dysfunction during Sepsis
O. Huet, A. Harrois, J. Duranteau

7. Measurement of Carbon Monoxide: From Bench to Bedside
F. Corrêa, F. E. Nacul, Y. Sakr

8. Monitoring Immune Dysfunction in Septic Patients: Toward Tailored Immunotherapy
F. Venet, A. Lepape, G. Monneret

Section III. Current and Future Management of Sepsis

9. Source Control in the ICU
J. J. Waele, M. M. L. G. Malbrain, I. E. Laet

10. IgM-enriched Immunoglobulins in Sepsis
F. Esen, S. Tugrul

11. Clarithromycin: A Promising Immunomodulator in Sepsis
E. J. Giamarellos-Bourboulis

12. High-flow Hemofiltration as an Adjunctive Therapy in Sepsis
P. M. Honoré, O. Joannes-Boyau, W. Boer

13. Economic and Social Burden of Severe Sepsis
E. Silva, D. V. Araujo

Section IV. Proposed Targets for New Therapies

14. Lymphocyte Apoptosis in Sepsis and Potential Anti-apoptotic Strategies
S. Weber, B. Baessler, S. Schroeder

15. The Pivotal Role of Beta-adrenoreceptors in Critical Illness Pathophysiology
G. L. Ackland, A. J. Patterson

16. Non-septic Acute Lung Injury and Inflammation: Role of TLR4
E. Lorne, H. Dupont, E. Abraham

17. Hydrogen Sulfide: A Metabolic Modulator and a Protective Agent in Animal Models of Reperfusion Injury
C. Szabó, P. Asfar, P. Radermacher

Section V. Septic Shock

18. ‘Myocardial Depression’ or’ septic Cardiomyopathy’?
K. Werdan, A. Oelke, U. Müller-Werdan

19. Determinants of Tissue PCO2 in Shock and Sepsis: Relationship to the Microcirculation
A. Dubin, V. S. K. Edul, C. Ince

20. Refining the Tools for Early Goal-directed Therapy in Septic Shock
E. Kipnis, E. Robin, B. Vallet

Section VI. Intravenous Fluids

21. Hyperchloremic Metabolic Acidosis: More than Just a Simple Dilutional Effect
S. S. Abdel-Razeq, L. J. Kaplan

22. Old versus New Starches: What do We Know about their Differences?
C. Hartog, F. M. Brunkhorst, K. Reinhart

23. Impact of Hydroxyethyl Starch on Renal Function
G. Marx, L. Hüter, T. Schuerholz

24. Rational Approach to Fluid Therapy in Acute Diabetic Ketoacidosis
J. Ochola, B. Venkatesh

Section VII. Hemodynamic Support

25. Cardiac Filling Volumes and Pressures in Assessing Preload Responsiveness during Fluid Challenges
R.-M. B. G. E. Breukers, R. J. Trof, A. B. J. Groeneveld

26. Update on preload indexes: More volume than pressure
G. Rocca, M. G. Costa, L. Spagnesi

27. Monitoring Arterial Blood Pressure and Cardiac Output using Central or Peripheral Arterial Pressure Waveforms
J. Smith, L. Camporota, R. Beale

28. Intrathoracic Pressure Regulation for the Treatment of Hypotension
I. Cinel, A. Metzger, R. P. Dellinger

29. Functional Hemodynamic Monitoring: A Personal Perspective
M. R. Pinsky

Section VIII. Airway Management

30. Endotracheal Intubation in the ICU
S. Jaber, B. Jung, G. Chanques

31. Pediatric Advanced Airway Management Training for Non-anesthesia Residents
A. Nishisaki, V. M. Nadkarni, R. A. Berg

32. Automatic Tube Compensation in the Weaning Process
J. Cohen, M. Shapiro, P. Singer

Section IX. Mechanical Ventilation

33. Extracorporeal Membrane Oxygenation for Cardiac and Pulmonary Indications: Improving Patient Safety
R. Kopp, S. Leonhardt, S. Kowalewski

34. Patient-ventilator Interaction during Non-invasive Ventilation
P. Jolliet, D. Tassaux, L. Vignaux

35. Variable Mechanical Ventilation: Breaking the Monotony
M. Gama de Abreu, P. M. Spieth, P. Pelosi

36. Life-threatening Asthma: Focus on Lung Protection
H. Quiroz Martínez, N. D. Ferguson

Section X. Respiratory Monitoring

37. Bedside Monitoring of Diaphragm Electrical Activity during Mechanical Ventilation
C. Sinderby, L. Brander, J. Beck

38. Electrical Impedance Tomography
E. L. V. Costa, R. Gonzalez Lima, M. B. P. Amato

39. Regional Ventilation Delay Index: Detection of Tidal Recruitment using Electrical Impedance Tomography
T. Muders, H. Luepschen, C. Putensen

40. Different Approaches to the Analysis of Volumetric Capnography
F. Suarez Sipmann, S. H. Böhm, G. Tusman

41. Variation in Extravascular Lung Water in ALI/ARDS Patients using Open Lung Strategy
F. J. Belda, G. Aguilar, C. Ferrando

42. Clinical Utility of Extravascular Lung Water Measurements
X. Monnet, J.-L. Teboul

Section XI. Perioperative Management

43. Rationalizing the Use of Surgical Critical Care: The Role of Cardiopulmonary Exercise Testing
S. J. Davies, R. J. T. Wilson

44. Advanced Minimally Invasive Hemodynamic Monitoring of the High-risk Major Surgery Patient
D. W. Green

45. Post-pneumonectomy Pulmonary Edema
D. Cook, E. Powell, F. Gao-Smith

46. The Role of Phenylephrine in Perioperative Medicine
C. Ertmer, A. Morelli, M. Westphal

47. Role of the Calcium Sensitizer, Levosimendan, in Perioperative Intensive Care Medicine
S. Rehberg, P. Enkhbaatar, D. L. Traber

48. Inhaled Nitric Oxide Therapy in Adult Cardiac Surgery
B. C. Creagh-Brown, T. W. Evans

Section XII. Cardiac Function

49. Use of Natriuretic Peptides in the Emergency Department and the ICU
T. Reichlin, M. Noveanu, C. Mueller

50. Abnormalities of the ST Segment
D. Gallo, J. M. Pines, W. Brady

51. Functional Mitral Regurgitation in the Critically Ill
J. Poelaert

Section XIII. Cardiopulmonary Resuscitation

52. Feedback to Improve the Quality of CPR
J. Yeung, J. Soar, G. D. Perkins

53. The Post-cardiac Arrest Syndrome
J. P. Nolan, R. W. Neumar

54. Use of a Standardized Treatment Protocol for Post-cardiac Resuscitation Care
M. A. Kuiper, P. E. Spronk, M. J. Schultz

55. Therapeutic Hypothermia after Cardiac Arrest
G. Ristagno, W. Tang

Section XIV. Renal Function

56. Biomarkers of Acute Kidney Injury in Critical Illness
F. Adams, B. Venkatesh

57. The Role of Biomarkers in Cardiac Surgery-associated Acute Kidney Injury
A. Shaw, M. Stafford-Smith, M. Swaminathan

58. Neutrophil Gelatinase-associated Lipocalin: An Emerging Biomarker for Angina Renalis
P. Devarajan

Section XV. Hepatosplanchnic Function

59. How does Intra-abdominal Pressure Affect the Daily Management of My Patients?
I. E. Laet, J. J. Waele, M. L. N. G. Malbrain

60. ICG Clearance Monitoring in ICU Patients
E. Levesque, F. Saliba

61. Acute-on-Chronic Liver Failure in Cirrhosis: Defining and Managing Organ Dysfunction
D. Shawcross, J. Wendon

Section XVI. Nutrition

62. The Curse of Overfeeding and the Blight of Underfeeding
N.-H. W. Loh, R. D. Griffiths

63. Enteral Feeding during Circulatory Failure: Myths and Reality
M. M. Berger, R. L. Chiolero

64. Enteral Nutrition with Anti-inflammatory Lipids in ALI/ARDS
A. Pontes-Arruda, S. J. DeMichele

65. Glutamine Supplementation in ICU Patients
A. Berg, O. Rooyackers, J. Wernerman

Section XVII. Glucose Control

66. Burn Causes Prolonged Insulin Resistance and Hyperglycemia
G. G. Gauglitz, M. G. Jeschke

67. Glucose Variability in Critically Ill Patients
N. A. Ali, J. S. Krinsley, J.-C. Preiser

Section XVIII. Adrenal Function

68. Corticosteroid Biology in Critical Illness: Modulatory Mechanisms and Clinical Implications
M. Williams, D. K. Menon

69. Corticosteroid Treatment of Patients in Septic Shock
C. L. Sprung, S. Goodman, Y. G. Weiss

Section XIX. Coagulation

70. New Anticoagulants: Anti-IIa or Anti-Xa Agents?
C. M. Samama

71. Emergency Reversal of Anticoagulants
M. Levi

Section XX. Neurological Aspects

72. The Role of Imaging in Acute Brain Injury
R. D. Stevens, A. Pustavoitau, P. Zijl

73. Monitoring and Managing Raised Intracranial Pressure after Traumatic Brain Injury
M. Smith

74. Sepsis-associated Encephalopathy
S. Siami, A. Polito, T. Sharshar

Section XXI. Malignancies

75. Acute Tumor Lysis Syndrome: Diagnosis and Management
M. Darmon, M. Roumier, E. Azoulay

76. Life-threatening Neurological Complications in Patients with Malignancies
S. Legriel, E. Azoulay

77. Should We Admit Critically Ill Cancer Patients to the ICU?
D. D. Benoit, P. O. Depuydt, J. M. Decruyenaere

Section XXII. Drug Dosing

78. Optimizing Drug Dosing in the ICU
X. Liu, P. Kruger, M. S. Roberts

79. Relevant CYP450-mediated Drug Interactions in the ICU
I. Spriet, W. Meersseman

Section XXIII. Sedation and Analgesia

80. Sedation and Pain Management in the ICU
M. A. Mirski, J. J. Lewin

81. The Role of Dexmedetomidine in Intensive Care
R. Rahman West, A. Rhodes, R. M. Grounds

82. Monitoring Delirium in the ICU
M. Seeling, A. Heymann, C. Spies

Section XXIV. ICU Management

83. Intensive Care for the Elderly: Current and Future Concerns
H. Wunsch, A. T. Jones, D. C. Scales

84. ICU Performance: Managing with Balanced Scorecards
K. Shukri, F. S. M. Ali

Section XXV. End-of-Life Issues

85. Towards a Neuro-scientific Explanation of Near-death Experiences?
A. Vanhaudenhuyse, M. Thonnard, S. Laureys

86. Managing Conflict at the End-of-Life
K. Hillman, J. Chen

87. Strengths and Weaknesses of Substitute Decision Making in the ICU
A. Lautrette, E. Azoulay, B. Souweine

Nyckelord: Medicine & Public Health, Intensive / Critical Care Medicine, Emergency Medicine, Internal Medicine